Abstract
Oropharyngeal candidiasis is a frequent cause of morbidity in patients with defects in cell-mediated immunity or saliva production. Animal models of this infection are important for studying disease pathogenesis and evaluating vaccines and antifungal therapies. Here we describe a simple mouse model of oropharyngeal candidiasis. Mice are rendered susceptible to oral infection by injection with cortisone acetate and then inoculated by placing a swab saturated with Candida albicans sublingually. This process results in a reproducible level of infection, the histopathology of which mimics that of pseudomembranous oropharyngeal candidiasis in humans. By using this model, data are obtained after 5–9 d of work.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sangeorzan, J.A. et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97, 339–346 (1994).
Rhodus, N.L., Bloomquist, C., Liljemark, W. & Bereuter, J. Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome. J. Otolaryngol. 26, 300–305 (1997).
Willis, A.M. et al. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet. Med. 16, 675–679 (1999).
Redding, S.W. et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J. Clin. Microbiol. 37, 3896–3900 (1999).
Arribas, J.R. et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 14, 979–985 (2000).
Martins, M.D., Lozano-Chiu, M. & Rex, J.H. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 27, 1291–1294 (1998).
Kerdpon, D. et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis. 10, 138–144 (2004).
Chidzonga, M.M. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis. 9, 317–322 (2003).
Revankar, S.G. et al. Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients. Clin. Infect. Dis. 26, 960–963 (1998).
Pappas, P.G. et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 503–535 (2009).
Conti, H.R. et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206, 299–311 (2009).
Saunus, J.M. et al. Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis. Mol. Oral Microbiol. 25, 343–356 (2010).
Ho, A.W. et al. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J. Immunol. 185, 1063–1070 (2010).
Nett, J.E., Marchillo, K., Spiegel, C.A. & Andes, D.R. Development and validation of an in vivo Candida albicans biofilm denture model. Infect. Immun. 78, 3650–3659 (2010).
Sun, J.N. et al. Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog. 6, e1001181 (2010).
Chiang, L.Y. et al. Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis. Cell Microbiol. 9, 233–245 (2007).
Park, H. et al. Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol. 7, 499–510 (2005).
Kamai, Y., Kubota, M., Hosokawa, T., Fukuoka, T. & Filler, S.G. Contribution of Candida albicans ALS1 to the pathogenesis of experimental oropharyngeal candidiasis. Infect. Immun. 70, 5256–5258 (2002).
Dwivedi, P. et al. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion. PLoS ONE 6, e16218 (2011).
Hao, B. et al. Candida albicans RFX2 encodes a DNA binding protein involved in DNA damage responses, morphogenesis, and virulence. Eukaryot. Cell 8, 627–639 (2009).
Marquis, M. et al. CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Infect. Immun. 74, 2382–2391 (2006).
Sundstrom, P., Balish, E. & Allen, C.M. Essential role of the Candida albicans transglutaminase substrate, hyphal wall protein 1, in lethal oroesophageal candidiasis in immunodeficient mice. J. Infect. Dis. 185, 521–530 (2002).
Wolf, J.M., Johnson, D.J., Chmielewski, D. & Davis, D.A. The Candida albicans ESCRT pathway makes Rim101-dependent and -independent contributions to pathogenesis. Eukaryot. Cell 9, 1203–1215 (2010).
Spellberg, B.J. et al. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. J. Infect. Dis. 194, 256–260 (2006).
Kamai, Y., Kubota, M., Hosokawa, T., Fukuoka, T. & Filler, S.G. New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemother. 45, 3195–3197 (2001).
Rahman, D., Mistry, M., Thavaraj, S., Challacombe, S.J. & Naglik, J.R. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes. Infect. 9, 615–622 (2007).
Naglik, J.R., Fidel, P.L. Jr. & Odds, F.C. Animal models of mucosal Candida infection. FEMS Microbiol. Lett. 283, 129–139 (2008).
Rachelefsky, G.S., Liao, Y. & Faruqi, R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann. Allergy Asthma Immunol. 98, 225–238 (2007).
Farah, C.S. et al. Primary role for CD4+ T lymphocytes in recovery from oropharyngeal candidiasis. Infect. Immun. 70, 724–731 (2002).
Cantorna, M.T. & Balish, E. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58, 1093–1100 (1990).
de Repentigny, L. et al. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J. Infect. Dis. 185, 1103–1114 (2002).
Cheng, S. et al. The role of Candida albicans NOT5 in virulence depends upon diverse host factors in vivo. Infect. Immun. 73, 7190–7197 (2005).
Acknowledgements
This work was supported by grant R01DE017088 and contract no. N01-AI-30041 from the US National Institutes of Health.
Author information
Authors and Affiliations
Contributions
N.V.S. and S.G.F. performed the experiments, analyzed the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
S.G.F. is a cofounder of and has equity in NovaDigm Therapeutics.
Rights and permissions
About this article
Cite this article
Solis, N., Filler, S. Mouse model of oropharyngeal candidiasis. Nat Protoc 7, 637–642 (2012). https://doi.org/10.1038/nprot.2012.011
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2012.011
This article is cited by
-
Transcription factor EGR2 controls homing and pathogenicity of TH17 cells in the central nervous system
Nature Immunology (2023)
-
Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections
Nature Communications (2022)
-
Tissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa
Mucosal Immunology (2021)
-
Halo-fluorescein for photodynamic bacteria inactivation in extremely acidic conditions
Nature Communications (2021)
-
Schiff-base silver nanocomplexes formation on natural biopolymer coated mesoporous silica contributed to the improved curative effect on infectious microbes
Nano Research (2021)